Administration of mesenchymal stem cells in diabetic kidney disease: a systematic review and meta-analysis.

Wenshan LinHong-Yan LiQian YangGuangyong ChenShujun LinChunling LiaoTianbiao Zhou

Published in: Stem cell research & therapy (2021)

MSCs might improve glycemic control and reduce SCr, BUN, and urinary protein. MSCs can also alleviate renal fibrosis. MSC therapy might be a potential treatment for DKD.

Keyphrases

mesenchymal stem cells
glycemic control
type diabetes
umbilical cord
blood glucose
bone marrow
cell therapy
weight loss
insulin resistance
human health
adipose tissue
amino acid
wound healing
risk assessment
replacement therapy
smoking cessation
liver fibrosis